ARCHIVES

Cooperative Groups, NCI To Talk About Overlaps

This article is from The Cancer Letter archive.

Vol. 01 No. 11 | March 14, 1975

Download PDF Visit The Full Archive

Related Articles

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

CAN-DIAL Test Generates 16,000 Calls for Cancer Information

December 13, 1974

Mouse Strains For Retrovirus Research Available From NCU

March 23, 1984

NS Sponsors Workshop On Prevention For Three Minority Groups

July 1, 1988

NCI CTEP-Approved Trials For the Month of July

July 25, 2014

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004